{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:37:10Z","timestamp":1780504630386,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbrc.2019.11.155","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T01:18:33Z","timestamp":1574903913000},"page":"604-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy"],"prefix":"10.1016","volume":"522","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-2059","authenticated-orcid":false,"given":"Adeleye O.","family":"Adeshakin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funmilayo O.","family":"Adeshakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3745-1860","authenticated-orcid":false,"given":"Xiaochun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.11.155_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature22348","article-title":"Erratum: effective combinatorial immunotherapy for castration-resistant prostate cancer","volume":"545","author":"Lu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.11.155_bib2","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.11.155_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2010.01.021","article-title":"Myeloid-derived suppressor cell heterogeneity and subset definition","volume":"22","author":"Peranzoni","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib4","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib5","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MOH.0000000000000196","article-title":"Interferon regulatory factor 8 and the regulation of neutrophil, monocyte, and dendritic cell production","volume":"23","author":"Yanez","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib7","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/sj.leu.2403472","article-title":"Impaired myelopoiesis in mice devoid of interferon regulatory factor 1","volume":"18","author":"Testa","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2019.11.155_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20151764","article-title":"The macrophage IRF8\/IRF1 regulome is required for protection against infections and is associated with chronic inflammation","volume":"213","author":"Langlais","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2019.11.155_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/onc.2009.334","article-title":"Histone deacetylases and the immunological network: implications in cancer and inflammation","volume":"29","author":"Villagra","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2019.11.155_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jphs.2018.06.014","article-title":"Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells","volume":"137","author":"Xie","year":"2018","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2019.11.155_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ni.2526","article-title":"Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer","volume":"14","author":"Youn","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib13","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3389\/fimmu.2018.01922","article-title":"GM-CSF quantity has a selective effect on granulocytic vs. Monocytic myeloid development and function","volume":"9","author":"Sun","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2019.11.155_bib15","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.4049\/jimmunol.1402412","article-title":"IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation","volume":"194","author":"Paschall","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","article-title":"Transcriptional regulation of myeloid-derived suppressor cells","volume":"98","author":"Condamine","year":"2015","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib17","first-page":"3833","article-title":"TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice","volume":"117","author":"Calzascia","year":"2007","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.11.155_bib18","first-page":"1","article-title":"The diverse roles of the TNF axis in cancer progression and metastasis","volume":"11","author":"Ham","year":"2016","journal-title":"Trends Cancer Res."},{"key":"10.1016\/j.bbrc.2019.11.155_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer, Nature reviews","volume":"1","author":"Johnstone","year":"2002","journal-title":"Drug Discov."},{"key":"10.1016\/j.bbrc.2019.11.155_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1189\/jlb.0311119","article-title":"Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in\u00a0vitro and in\u00a0vivo","volume":"91","author":"Rosborough","year":"2012","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib21","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20050324","article-title":"Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells","volume":"201","author":"Yao","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2019.11.155_bib22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.4049\/jimmunol.177.2.1282","article-title":"Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription","volume":"177","author":"Zhang","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1105166","article-title":"Stat3 dimerization regulated by reversible acetylation of a single lysine residue","volume":"307","author":"Yuan","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2019.11.155_bib24","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-LB-295","article-title":"Abstract LB-295: a novel regulatory role of HDAC6 in the functional inflammatory phenotype of glia cells","volume":"77","author":"Kim","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2019.11.155_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcp.2016.03.010","article-title":"HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-kappaB p65 transcriptional activity","volume":"108","author":"Leus","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nri3790","article-title":"Clinical blockade of PD1 and LAG3--potential mechanisms of action","volume":"15","author":"Nguyen","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2019.11.155_bib27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI96061","article-title":"PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression","volume":"128","author":"Tang","year":"2018","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.11.155_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/1535-7163.MCT-18-1068","article-title":"HDAC3 inhibition upregulates PD-L1 expression in B-cell lymphomas and augments the efficacy of anti\u2013PD-L1 therapy","volume":"18","author":"Deng","year":"2019","journal-title":"Mol. Cancer Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19322831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19322831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:44:37Z","timestamp":1757763877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19322831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0006291X19322831"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.11.155","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.11.155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}